No Data
No Data
China National Nuclear Radiation (300962.SZ): net income increased by 1.08% year-on-year in the first half of the year.
On July 4th, Gelonhui released its half-year performance report. The company achieved a total operating income of CNY 178,794,328.16, a YoY increase of 5.44%, and an operating profit of CNY 77,762,857.60, a YoY increase of 1.45%. The total profit was CNY 77,350,914.61, a YoY increase of 0.93%, and the net income attributable to shareholders of the listed company was CNY 64,682,464.32, a YoY increase of 1.08%. As of June 30, 2024, the company's total assets were 1, and so on.
Zhongjin Irradiation Incorporated: China National Nuclear Corporation Radiation Co., Ltd. 2024 Semi-Annual Performance Bulletin.
Zhongjin Radiation (300962.SZ): Radiation technology can be applied to aging performance experiments of electronic components for aerospace satellites.
On July 3rd, Gelunhui reported that a investor asked Zhongjin Radiant (300962.SZ) on the investor interactive platform, "Can the company's radiation technology be used for commercial aerospace?" The company replied that radiation technology can be applied to the aging performance test of electronic components in aerospace satellites, using gamma rays generated by cobalt decay to design experiments that simulate the radiation environment of space, and test the radiation resistance level and material performance changes of satellite electronic components under specific radiation conditions.
Zhongjin Radiological (300962.SZ): Currently, cobalt-60 irradiation devices and electron accelerator irradiation devices are available to provide polymer material irradiation modification services.
On July 3rd, Guolonghui reported that an investor asked Zhongjin Radiography (300962.SZ) on the investor communication platform: "How many production lines does the company currently have for new material modification business?" The company replied that the cobalt-60 irradiation device and the electronic accelerator irradiation device of the company can both provide polymer material irradiation modification services.
China Gold only has nuclear technology application business in Zhongjin Irradiation (300962.SZ).
On July 3rd, Gelunhui reported that Zhongjin Fuzhao (300962.SZ) said on the investor interaction platform that, other than nuclear technology applications in which China Gold Group is involved, there are currently no other nuclear-related businesses.
China National Nuclear Corporation Radiology (300962.SZ): Equity distribution for the year 2023 is 10 dividends of 2.9 yuan. Record date is June 18.
On June 11th, Guolonghui reported that Zhongjin Radiation (300962.SZ) announced its annual equity distribution plan for 2023: based on a total share capital of 264,001,897 shares, all shareholders will be paid RMB 2.900000 in cash (including tax) for every 10 shares. The equity distribution registration date for this distribution is June 18, 2024; the ex-dividend date is June 19, 2024.
No Data